Overview
Registration
Accommodations
Agenda
Faculty
Keynote
Opportunities
Satellite Symposia

Accreditation/
Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians’ Education Resource®, LLC, and Pharmacy Times Continuing Education. Physicians’ Education Resource®, LLC, is accredited by the ACCME to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 24.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACPE

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 21.75 contact hours (2.175 CEUs) under the ACPE universal activity numbers:
0290-9999-19-196-L01-P
0290-9999-19-197-L01-P
0290-9999-19-198-L01-P

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 24.25 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AbbVie Inc.; AstraZeneca; Athenex; Celgene Corporation; Daiichi Sankyo, Inc.; Eisai; Exelixis, Inc.; Genomic Health; Incyte Corporation; MacroGenics, Inc.; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Pfizer; Regeneron; Sanofi Genzyme; Seattle Genetics, Inc.; and Taiho Oncology, Inc.

37th Annual CFS®: Innovative Cancer Therapy for Tomorrow

37th Annual CFS®: Innovative Cancer Therapy for Tomorrow


37th Annual CFS®

Wednesday, November 6, 2019 – Friday, November 8, 2019

New York Marriott Marquis
1535 Broadway
New York, NY 10036
212-398-1900

Hear About Last Year's Event From Leading Oncologists Who Attended

37th Annual Chemotherapy Foundation Symposium Overview

Exciting new breakthroughs and rapid changes continue to occur in the management of solid and hematologic malignancies. Just this past year, practice-changing diagnostic, therapeutic, and supportive care strategies have entered clinical practice, and many more are poised to enter the field. The application of optimized testing approaches, locoregional and systemic therapies, including the use of chemotherapies, targeted therapies, immunotherapies, alone and in combination, along with multimodal strategies, continue to drive improved outcomes across multiple lines of care. Critical knowledge, competence, and performance gaps among practitioners must be addressed to ensure that these approaches are effectively and safely integrated into professional practice.

Each year, the Chemotherapy Foundation Symposium® (CFS®), brings together more than 1,000 healthcare professionals for 3 days, with the aim of promoting the delivery of evidence-based, state-of-the-art cancer care for both routine and the most challenging clinical scenarios. At the 37th Annual CFS®, our internationally renowned faculty will provide you with expert insights on the latest developments in cancer therapeutics, offering an unparalleled opportunity to learn how innovative approaches fit into existing treatment paradigms to optimize care and outcomes for your patients with cancer.

Benefits of Attending
  • Incorporate the latest clinical data and evidence-based strategies into your practice
  • Learn experts’ viewpoints on areas of clinical uncertainty
  • Network with the top minds in oncology
  • 100 Experts. 25 Tumor Types. 3 Days. 1 Meeting. Something for everyone!
Target Audience

This educational activity is directed toward oncologists, hematologists, nurses, nurse practitioners, and pharmacists involved in the treatment/management of patients with cancer. Radiotherapists, immunologists, fellows, physician assistants, researchers, case managers, and other healthcare professionals interested in the treatment of cancer are also invited to attend.

Learning Objectives

Upon completion of this activity, participants should be better prepared to:

  • Review key testing strategies across tumor types for identification of tumor markers for prognostic/predictive assessment and selection of appropriate treatment
  • Recognize practice-changing results to inform improved diagnosis, treatment, and adverse event management across solid and liquid tumors
  • Identify ways of translating novel evidence-based treatment strategies using immunotherapeutic, targeted treatment, and chemotherapeutic treatment strategies into clinical practice
  • Learn strategies for promoting multidisciplinary best practices in the proactive management of treatment-related toxicities
  • Analyze practice-changing evidence presented at major conferences and apply these findings to improve the treatment of patients with cancer
Acknowledgment of Commercial Support

This activity is supported by educational grants from AbbVie Inc.; AstraZeneca; Athenex; Celgene Corporation; Daiichi Sankyo, Inc.; Eisai; Exelixis, Inc.; Genomic Health; Incyte Corporation; MacroGenics, Inc.; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Pfizer; Regeneron; Sanofi Genzyme; Seattle Genetics, Inc.; and Taiho Oncology, Inc.

37th Annual Chemotherapy Foundation Symposium Co-Chairs

Adam M. Brufsky
Adam M. Brufsky, MD, PhD
Professor of Medicine
Associate Chief, Division of Hematology/Oncology
Co-Director, Comprehensive Breast Cancer Center
Associate Director, Translational Investigation
University of Pittsburgh
Pittsburgh, PA
 
Benjamin Levy
Benjamin P. Levy, MD
Associate Professor, Johns Hopkins School of Medicine
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center
Sibley Memorial Hospital
Washington, DC
 
William K. Oh
William K. Oh, MD
Chief, Division of Hematology and Medical Oncology
Deputy Director, Tisch Cancer Institute
Professor of Medicine and Urology
Ezra M. Greenspan, MD, Professor in Clinical Cancer Therapeutics
Icahn School of Medicine at Mount Sinai
New York, NY

37th Annual Chemotherapy Foundation Symposium Registration

Physicians' Education Resource
2 Clarke Drive, Suite 110
Cranbury, NJ 08512

  Advance On-Site
Physicians $599 $699
Fellows* $249 $349
Nurses, PAs, Other Health Care Professionals $249 $349
Industry** $749 $849

Daily rates are now available, please call (877) 303-0104 for pricing.

*FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount. Cannot be combined with other discounts/coupon codes.
**INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.

For registration assistance, please email info@gotoper.com, or call (877) 303-0104.

A cancellation fee of 25% will be assessed on refunds requested through and including September 26, 2019, and a 50% fee applies to refunds requested from September 27, 2019 through October 24, 2019. No refunds will be made after October 24, 2019. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.

In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image").  By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as part of the Affordable Care Act. Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.




Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


Professional Information


Specialties*

Submit
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
Filter By